Probiotics to help prevent gestational diabetes in pregnant women at high risk
Tests probiotics against placebo in pregnant women at high risk of gestational diabetes.
Key facts
- Who runs it
- Women's Hospital School Of Medicine Zhejiang University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Registry title
- Preventive Effect of Probiotics in GDM
- Status
- Recruiting
- People taking part
- 334 people, planned
- Started
- 27 Oct 2023
- Planned end
- 1 Nov 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Probiotics
- Placebo
- Record updated
- 27 April 2025
Who can take part
The trial is looking for pregnant women at high risk of diabetes in pregnancy (gestational diabetes). They will take probiotic powder or a placebo (dummy powder) each day.
- Age
- 18 Years to 50 Years
- Sex
- Women only
- Disease stage
- Pregnant between 12-16 gestational weeks. You must have at least one high-risk sign: pre-pregnancy BMI ≥ 24 kg/m^2, family history of diabetes (type 1 or 2), past gestational diabetes or PCOS (polycystic ovary syndrome), a past very large baby (macrosomia) or stillbirth, or sugar in the urine.
- Earlier treatment
- You cannot have taken probiotics or prebiotics within the past month.
- Main reasons for not taking part
- Type 1 or type 2 diabetes diagnosed before pregnancy
- Allergy to the study product parts or similar products
- Long-term smoking or drinking habits
- Serious disease of the heart, liver, kidney or digestive system
- Pregnant with more than one baby
This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnant women who meet the high-risk indicators for GDM and agree to participate in this study.
Show the full registry criteria (9)Hide the full registry criteria
Who can take part
- Pregnant women who meet the high-risk indicators for GDM and agree to participate in this study; included between 12-16 gestational weeks; A woman was considered high risk when her pre-pregnancy BMI ≥ 24 kg/m\^2, having family history of diabetes (type 1 or 2), GDM or PCOS (polycystic ovary syndrome) history, history of delivering macrosomia or stillbirth, or glucose in urine (+)
Who cannot take part
- Have a history of allergies to the drug components or similar drugs in this study
- Type 1 or type 2 diabetes patients with definite diagnosis before pregnancy
- Diseases in other important organs such as heart, liver, and kidney
- with clear digestive system diseases
- Taking probiotics or prebiotics within the past month
- Having long-term smoking or drinking habits
- Multiple pregnancy
- with mental or cognitive impairments who are unable to complete this study
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
- Gestational diabetes mellitus
This trial is currently available in China.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Gut microbiota is instrumental in the microbial and metabolic network of pregnant women, and is potentially related with gestational diabetes. Perinatal probiotic intervention contributes to improved glucose regulation during pregnancy. Our randomized, double-centered, placebo-controlled study is planned to recruit 334 pregnant women who is in high risk for gestational diabetes. They will be assumed randomly probiotic powder per day or placebo from 12-16th gestational weeks until Oral Glucose Tolerance Test (OGTT) at 24-28th gestational weeks. Perinatal outcomes about neonatal weight will be registered.
The 2 groups in the trial
- ProbioticsExisting treatment, for comparison
Probiotic powder 1 bag per day, as well as health guidance about diet and exercise. From recruitment until OGTT.
- PlaceboPlacebo, for comparison
Placebo 1 bag per day. Similar health guidance about diet and exercise. From recruitment until OGTT
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 3 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- The Preventive Effect of Probiotics in Pregnant Women With High-risk for Gestational Diabetes
- Plain-language title
- Probiotics to help prevent gestational diabetes in pregnant women at high riskGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 15 November 2026.
- Criteria questions
- Built from NCT06938464, who can take part
- Record updated
- 27 April 2025